Showing results (271-280 of 583) with videos related to
Sort By:
Pageof 59
The Journal of Steroid Biochemistry and Molecular Biology|May 28, 2003
Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivoSamer Haidar, Peter B Ehmer, Stephan Barassin, et al.European Journal of Medicinal Chemistry|March 5, 2014
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infectionsStefan Hinsberger, Johannes C de Jong, Matthias Groh, et al.European Journal of Pediatrics|April 1, 1990
Serum immunoreactive erythropoietin of children in health and diseaseK U Eckardt, W Hartmann, U Vetter, et al.ACS Chemical Biology|January 22, 2013
Peptide-based investigation of the Escherichia coli RNA polymerase σ(70):core interface as target siteKristina Hüsecken, Matthias Negri, Martina Fruth, et al.Future Medicinal Chemistry|November 5, 2014
Surface plasmon resonance--more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitorsKristina Hüsecken, Stefan Hinsberger, Walid A M Elgaher, et al.Bioorganic Chemistry|October 16, 2012
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroidsRanju Bansal, Sridhar Thota, Nalin Karkra, et al.Biochemical and Biophysical Research Communications|July 11, 2016
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesisSameer S Udhane, Bernhard Dick, Qingzhong Hu, et al.Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.Journal of Medicinal Chemistry|June 9, 1995
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 aromR W Hartmann, H Bayer, G Grün, et al.Pageof 59